Species |
Human |
Protein Construction |
DLL4 (Ser27-Pro524) Accession # Q9NR61 |
His |
N-term |
C-term |
|
Conjugate |
Biotin |
Purity |
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Immobilized DLL4[Biotin], His, Human (Cat.No.: Z03956) at 2 μg/ml (100μl/Well) on the streptavidin precoated plate can bind Anti-DLL4 Antibody, hFc Tag |
Expression System |
HEK293 |
Theoretical Molecular Weight |
55.7 kDa |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 62-68 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from a 0.22 μm filtered solution in PBS, 200mM L-arginine(pH 7.4). |
Reconstitution |
It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
![DLL4[Biotin], His, Human DLL4[Biotin], His, Human](/product/documents/down?doc_name=Z03956 PAGE.png&file=scm_files/productFile_notes/2025/04/02/676d51a7-0d32-4d01-adfa-150907aa5494.png)
DLL4[Biotin], His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
![DLL4[Biotin], His, Human DLL4[Biotin], His, Human](/product/documents/down?doc_name=Z03956 HPLC.png&file=scm_files/productFile_notes/2025/04/02/832ecaf5-84ba-43c0-be3b-cc8c8df390cb.png)
The purity of DLL4[Biotin], His, Human is greater than 95% as determined by SEC-HPLC.
![DLL4[Biotin], His, Human DLL4[Biotin], His, Human](/product/documents/down?doc_name=Z03956 ELISA.jpg&file=scm_files/productFile_notes/2025/04/02/4f0368c3-3236-4587-9755-892c69c3fe88.jpg)
Immobilized DLL4[Biotin], His, Human at 2 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-DLL4 Antibody, hFc Tag with the EC50 of 3.5 ng/ml determined by ELISA.
Target Background |
Delta-like protein 4 (DLL4) is a type I transmembrane protein with a DSL domain and eight tandem EGF repeats. DLL4 functions as a Notch ligand and activates NOTCH1 and NOTCH4 in the Notch signaling pathway. It is involved in vascular development and homeostasis. DLL4 is involved in vascular development and homeostasis. It is highly expressed in some cancers, such as bladder, breast cancers. |
Synonyms |
DLL4; MGC126344; notch ligand DLL4; Delta4; Delta-like 4 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.